- Filed
- Mar 28, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2023 · Mar 25, 2024 | 8M sh |
| Shares Diluted restated | FY 2023 · Dec 31, 2022 | 8M sh |
| Capex | FY 2023 · Dec 31, 2022 | $1K |
| Operating Cash Flow | FY 2023 · Dec 31, 2022 | $332K |
| Current Liabilities | FY 2023 · Dec 31, 2022 | $4.64M |
| Total Liabilities | FY 2023 · Dec 31, 2022 | $5.36M |
| Current Assets | FY 2023 · Dec 31, 2022 | $2.96M |
| Total Assets | FY 2023 · Dec 31, 2022 | $5.14M |
| Eps Diluted | FY 2023 · Dec 31, 2022 | −$0.04 |
| Eps Basic | FY 2023 · Dec 31, 2022 | −$0.04 |
| Sga Expense | FY 2023 · Dec 31, 2022 | $3.36M |
| Rd Expense | FY 2023 · Dec 31, 2022 | $492K |
| Net Income | FY 2023 · Dec 31, 2022 | −$331K |
| Operating Income | FY 2023 · Dec 31, 2022 | −$183K |
| Cost Of Revenue | FY 2023 · Dec 31, 2022 | $3.27M |
| Revenue | FY 2023 · Dec 31, 2022 | $8.18M |
| Stockholders Equity | FY 2023 · Dec 31, 2021 | −$4.59M |